BPG is committed to discovery and dissemination of knowledge
Meta-Analysis
Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 14, 2026; 32(46): 123374
Published online Dec 14, 2026. doi: 10.3748/wjg.123374
Table 3 Meta-analysis of extraintestinal manifestations in ulcerative colitis vs controls

Number of studies
OR (95%CI)
I2 value
Overall EIMs
UC compared to CD370.4676 (0.3596-0.6081)90.00%
UC compared to IC122.8806 (1.2901-405.7843)Ne
UC compared to ITB12.9765 (1.9716-4.4936)Ne
Arthritis
UC compared to CD830.6018 (0.5059-0.7159)86.70%
UC compared to IC31.0689 (0.1786-6.3983)0.00%
UC compared to ITB21.9731 (0.3509-11.0959)44.30%
UC compared to IBD-U50.552 (0.2304-1.3225)67.10%
UC compared to other20.4221 (0.0378-4.7080)86.50%
UC compared to HCs52.7051 (1.6184-4.5214)96.80%
Oral lesions
UC compared to CD510.3176 (0.2285-0.4414)61.80%
UC compared to IC22.1854 (0.0611-78.1549)63.10%
UC compared to ITB20.3614 (0.0125-10.4663)80.90%
UC compared to IBD-U50.5973 (0.2640-1.3518)15.20%
UC compared to other10.0029 (0.0003-0.0243)Ne
UC compared to HCs115.7109 (0.8862-278.5145)Ne
Dermatological manifestations
UC compared to CD720.5394 (0.4539-0.6411)56.40%
UC compared to ITB12.4982 (0.3267-19.1032)Ne
UC compared to IBD-U30.1441 (0.0783-0.2652)63.80%
UC compared to other10.0089 (0.0005-0.1678)Ne
UC compared to HCs51.9999 (1.4759-2.7101)61.40%
Ocular involvement
UC compared to CD450.6127 (0.4712-0.7968)57.90%
UC compared to IC12.5765 (0.1018-65.1991)Ne
UC compared to ITB12.333 (0.5494-9.9066)Ne
UC compared to IBD-U21.758 (0.2898-10.6648)0.00%
UC compared to HCs12.3863 (1.9858-2.8676)Ne
Hepatobiliary involvement
UC compared to CD441.2127 (0.8564-1.7171)82.20%
UC compared to ITB11.961 (0.1080-35.6005)Ne
UC compared to IBD-U21.5412 (0.8790-2.7021)0.00%
UC compared to other11.5086 (0.1948-11.6805)Ne
UC compared to HCs35.2312 (0.6907-39.6177)98.60%


Write to the Help Desk